HER2 Support Group Forums
>
Search Forums
Search Results
User Name
Remember Me?
Password
Register
Gallery
FAQ
Members List
Calendar
Search
Today's Posts
Mark Forums Read
Showing results 1 to 1 of 1
Search took
0.00
seconds.
Search:
Posts Made By:
Lani
Forum:
her2group
06-06-2015, 09:01 PM
Replies:
1
Dr. Slamon describes results of genomic seqncng to determine who benefits from adding
Views:
2,088
Posted By
Lani
Dr. Slamon describes results of genomic seqncng to determine who benefits from adding
everolimus (an mTor inhibitor which ffeecets the PI3k pathway) to herceptin in Stage IV patients
http://meetinglibrary.asco.org/content/112020?media=vm
Showing results 1 to 1 of 1
Forum Jump
User Control Panel
Private Messages
Subscriptions
Who's Online
Search Forums
Forums Home
her2group
Herceptin / Tykerb
Caregivers Corner
Diet and Nutrition
Inflammatory Breast Cancer
Keeping Your Mind Off of BC
Profiles In Courage
My Healthcare Team
Clinical Trials
Articles of Interest
Events and Social Calendar
Breast Cancer Meeting Highlights
General Cancer News
Breast Cancer News
Breast Cancer Newsfeed
All times are GMT -7. The time now is
11:03 AM
.
